The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
The presented expert paper discusses the high prevalence of hypercholesterolemia (HCH) in Russia. Insufficient use of lipid-lowering therapy in both primary and secondary prevention is indicated. Failure to achieve the target level of low-density lipoprotein cholesterol (HC) and low adherence (espec...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Concilium Medicum
2025-01-01
|
| Series: | КардиоСоматика |
| Subjects: | |
| Online Access: | https://cardiosomatics.ru/2221-7185/article/viewFile/676903/198223 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849425505922580480 |
|---|---|
| author | Marina G. Bubnova Albert S. Galyаvich Marat V. Ezhov David M. Aronov Natalia N. Vinogradova Gagik R. Galstyan Viktor S Gurevich Yuri A. Karpov Natalia A. Koziolova Elena D. Kosmacheva Gennady V. Matyushin Igor V. Sergienko Alexander E. Philippov Iurii Sh. Khalimov |
| author_facet | Marina G. Bubnova Albert S. Galyаvich Marat V. Ezhov David M. Aronov Natalia N. Vinogradova Gagik R. Galstyan Viktor S Gurevich Yuri A. Karpov Natalia A. Koziolova Elena D. Kosmacheva Gennady V. Matyushin Igor V. Sergienko Alexander E. Philippov Iurii Sh. Khalimov |
| author_sort | Marina G. Bubnova |
| collection | DOAJ |
| description | The presented expert paper discusses the high prevalence of hypercholesterolemia (HCH) in Russia. Insufficient use of lipid-lowering therapy in both primary and secondary prevention is indicated. Failure to achieve the target level of low-density lipoprotein cholesterol (HC) and low adherence (especially long-term) of patients to hypolipidemic drugs remains a serious problem in real clinical practice. Statins are a class of widely prescribed lipid-lowering drugs that are the first choice drugs in the treatment of HCV and combined hyperlipidemia (GLP) with proven efficacy in the prevention of atherosclerotic cardiovascular diseases. Using the example of the original pitavastatin, this expert document convincingly demonstrates the drug's capabilities not only in reducing atherogenic lipids and lipoproteins in blood plasma, but also its clinical effectiveness in the primary and secondary prevention of cardiovascular complications. This highlights the unique effect of pitavastatin on increasing low cholesterol levels of high-density lipoproteins, proven anti-atherosclerotic activity and a wide range of positive pleiotropic effects that enhance its antiatherogenic effect. The low risk of drug interactions inherent in pitavastatin highlights its high safety with prolonged use and good tolerability. All of the above gives grounds to consider the original pitavastatin as the drug of choice for a wide range of patients.
This article was previously published in: Bubnova MG, Galyavich AS, Ezhov MV, Aronov DM, Vinogradova NN, Galstyan GR, Gurevich VS, Karpov YuA, Koziolova NA, Kosmacheva ED, Matyushin GV, Sergienko IV, Filippov AE, Khalimov YuSh. The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists. Russian Journal of Cardiology. 2024;29(11):6148. doi: 10.15829/1560-4071-2024-6148. EDN: PSIJPF
The article was published with the consent of the author's team and the editorial board of the Russian Journal of Cardiology and does not contradict the Creative Commons Attribution 4.0 License. |
| format | Article |
| id | doaj-art-ffb549912e554ee7af46bb9e2f862284 |
| institution | Kabale University |
| issn | 2221-7185 2658-5707 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Concilium Medicum |
| record_format | Article |
| series | КардиоСоматика |
| spelling | doaj-art-ffb549912e554ee7af46bb9e2f8622842025-08-20T03:29:44ZengConcilium MedicumКардиоСоматика2221-71852658-57072025-01-0116152010.17816/CS67690376593The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of EndocrinologistsMarina G. Bubnova0https://orcid.org/0000-0003-2250-5942Albert S. Galyаvich1https://orcid.org/0000-0002-4510-6197Marat V. Ezhov2https://orcid.org/0000-0002-1518-6552David M. Aronov3https://orcid.org/0000-0003-0484-9805Natalia N. Vinogradova4Gagik R. Galstyan5https://orcid.org/0000-0001-6581-4521Viktor S Gurevich6https://orcid.org/0000-0002-6815-444XYuri A. Karpov7https://orcid.org/0000-0003-1480-0458Natalia A. Koziolova8https://orcid.org/0000-0001-7003-5186Elena D. Kosmacheva9https://orcid.org/0000-0001-8600-0199Gennady V. Matyushin10https://orcid.org/0000-0002-0150-6092Igor V. Sergienko11https://orcid.org/0000-0003-1534-3965Alexander E. Philippov12https://orcid.org/0000-0002-4413-5068Iurii Sh. Khalimov13https://orcid.org/0000-0002-7755-7275National Medical Research Center for Therapy and Preventive MedicineKazan State Medical UniversityNational Medical Research Center of Cardiology named after Academician E.I. ChazovaNational Medical Research Center for Therapy and Preventive MedicineClinical Hospital No. 1 (Volynskaya)National Medical Research Center for EndocrinologySt. Petersburg State UniversityNational Medical Research Center of Cardiology named after Academician E.I. ChazovaPerm State Medical University named after E.A. WagnerScientific Research Institute — Regional Clinical Hospital No. 1 named after Professor S.V. OchapovskyProfessor Voino-Yasenetsky Krasnoyarsk State Medical UniversityNational Medical Research Center of Cardiology named after Academician E.I. ChazovaSt. Petersburg State UniversityPavlov First St. Petersburg State Medical UniversityThe presented expert paper discusses the high prevalence of hypercholesterolemia (HCH) in Russia. Insufficient use of lipid-lowering therapy in both primary and secondary prevention is indicated. Failure to achieve the target level of low-density lipoprotein cholesterol (HC) and low adherence (especially long-term) of patients to hypolipidemic drugs remains a serious problem in real clinical practice. Statins are a class of widely prescribed lipid-lowering drugs that are the first choice drugs in the treatment of HCV and combined hyperlipidemia (GLP) with proven efficacy in the prevention of atherosclerotic cardiovascular diseases. Using the example of the original pitavastatin, this expert document convincingly demonstrates the drug's capabilities not only in reducing atherogenic lipids and lipoproteins in blood plasma, but also its clinical effectiveness in the primary and secondary prevention of cardiovascular complications. This highlights the unique effect of pitavastatin on increasing low cholesterol levels of high-density lipoproteins, proven anti-atherosclerotic activity and a wide range of positive pleiotropic effects that enhance its antiatherogenic effect. The low risk of drug interactions inherent in pitavastatin highlights its high safety with prolonged use and good tolerability. All of the above gives grounds to consider the original pitavastatin as the drug of choice for a wide range of patients. This article was previously published in: Bubnova MG, Galyavich AS, Ezhov MV, Aronov DM, Vinogradova NN, Galstyan GR, Gurevich VS, Karpov YuA, Koziolova NA, Kosmacheva ED, Matyushin GV, Sergienko IV, Filippov AE, Khalimov YuSh. The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists. Russian Journal of Cardiology. 2024;29(11):6148. doi: 10.15829/1560-4071-2024-6148. EDN: PSIJPF The article was published with the consent of the author's team and the editorial board of the Russian Journal of Cardiology and does not contradict the Creative Commons Attribution 4.0 License.https://cardiosomatics.ru/2221-7185/article/viewFile/676903/198223atherosclerosiscardiovascular diseasespreventionlipid-lowering therapystatinspitavastatin |
| spellingShingle | Marina G. Bubnova Albert S. Galyаvich Marat V. Ezhov David M. Aronov Natalia N. Vinogradova Gagik R. Galstyan Viktor S Gurevich Yuri A. Karpov Natalia A. Koziolova Elena D. Kosmacheva Gennady V. Matyushin Igor V. Sergienko Alexander E. Philippov Iurii Sh. Khalimov The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists КардиоСоматика atherosclerosis cardiovascular diseases prevention lipid-lowering therapy statins pitavastatin |
| title | The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists |
| title_full | The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists |
| title_fullStr | The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists |
| title_full_unstemmed | The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists |
| title_short | The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists |
| title_sort | place of original pitavastatin in primary and secondary prevention of cardiovascular diseases interdisciplinary expert consensus of the russian society of cardiology the national atherosclerosis society the russian society of cardiosomatic rehabilitation and secondary prevention and the russian association of endocrinologists |
| topic | atherosclerosis cardiovascular diseases prevention lipid-lowering therapy statins pitavastatin |
| url | https://cardiosomatics.ru/2221-7185/article/viewFile/676903/198223 |
| work_keys_str_mv | AT marinagbubnova theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT albertsgalyavich theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT maratvezhov theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT davidmaronov theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT natalianvinogradova theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT gagikrgalstyan theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT viktorsgurevich theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT yuriakarpov theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT nataliaakoziolova theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT elenadkosmacheva theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT gennadyvmatyushin theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT igorvsergienko theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT alexanderephilippov theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT iuriishkhalimov theplaceoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandthe AT marinagbubnova placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT albertsgalyavich placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT maratvezhov placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT davidmaronov placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT natalianvinogradova placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT gagikrgalstyan placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT viktorsgurevich placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT yuriakarpov placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT nataliaakoziolova placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT elenadkosmacheva placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT gennadyvmatyushin placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT igorvsergienko placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT alexanderephilippov placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus AT iuriishkhalimov placeoforiginalpitavastatininprimaryandsecondarypreventionofcardiovasculardiseasesinterdisciplinaryexpertconsensusoftherussiansocietyofcardiologythenationalatherosclerosissocietytherussiansocietyofcardiosomaticrehabilitationandsecondarypreventionandtherus |